Using small interfering RNA (siRNA)-mediated gene targeting to silence KLF6-SV1 expression can reduce the cell proliferation of GBM cell lines, which indicates that KLF6-SV1 overexpression can promote the proliferation of GBM cell lines. Here, KLF6 is linked to glioblastoma.